579 related articles for article (PubMed ID: 34549980)
1. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
Front Immunol; 2020; 11():591885. PubMed ID: 33224148
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
Webb EM; Azar SR; Haller SL; Langsjoen RM; Cuthbert CE; Ramjag AT; Luo H; Plante K; Wang T; Simmons G; Carrington CVF; Weaver SC; Rossi SL; Auguste AJ
Sci Rep; 2019 Dec; 9(1):20399. PubMed ID: 31892710
[TBL] [Abstract][Full Text] [Related]
4. Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
Powers JM; Haese NN; Denton M; Ando T; Kreklywich C; Bonin K; Streblow CE; Kreklywich N; Smith P; Broeckel R; DeFilippis V; Morrison TE; Heise MT; Streblow DN
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009308. PubMed ID: 33793555
[TBL] [Abstract][Full Text] [Related]
5. Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.
Bopp NE; Jencks KJ; Siles C; Guevara C; Vilcarromero S; Fernández D; Halsey ES; Ampuero JS; Aguilar PV
Am J Trop Med Hyg; 2021 Nov; 106(2):607-609. PubMed ID: 34844213
[TBL] [Abstract][Full Text] [Related]
6. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
[TBL] [Abstract][Full Text] [Related]
7. Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.
Malonis RJ; Earnest JT; Kim AS; Angeliadis M; Holtsberg FW; Aman MJ; Jangra RK; Chandran K; Daily JP; Diamond MS; Kielian M; Lai JR
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507983
[TBL] [Abstract][Full Text] [Related]
8. Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus.
Kantor AM; Lin J; Wang A; Thompson DC; Franz AWE
J Med Entomol; 2019 Apr; 56(3):832-843. PubMed ID: 30668762
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing Antibodies from Convalescent Chikungunya Virus Patients Can Cross-Neutralize Mayaro and Una Viruses.
Martins KA; Gregory MK; Valdez SM; Sprague TR; Encinales L; Pacheco N; Cure C; Porras-Ramirez A; Rico-Mendoza A; Chang A; Pitt ML; Nasar F
Am J Trop Med Hyg; 2019 Jun; 100(6):1541-1544. PubMed ID: 31017081
[TBL] [Abstract][Full Text] [Related]
10. Mayaro Virus Infects Human Brain Cells and Induces a Potent Antiviral Response in Human Astrocytes.
Bengue M; Ferraris P; Barthelemy J; Diagne CT; Hamel R; Liégeois F; Nougairède A; de Lamballerie X; Simonin Y; Pompon J; Salinas S; Missé D
Viruses; 2021 Mar; 13(3):. PubMed ID: 33799906
[TBL] [Abstract][Full Text] [Related]
11. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products.
Yue C; Teitz S; Miyabashi T; Boller K; Lewis-Ximenez LL; Baylis SA; Blümel J
Viruses; 2019 Mar; 11(3):. PubMed ID: 30866548
[TBL] [Abstract][Full Text] [Related]
12. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
Fumagalli MJ; de Souza WM; Romeiro MF; de Souza Costa MC; Slhessarenko RD; Figueiredo LTM
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787146
[TBL] [Abstract][Full Text] [Related]
13. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
García-Arriaza J; Cepeda V; Hallengärd D; Sorzano CÓ; Kümmerer BM; Liljeström P; Esteban M
J Virol; 2014 Mar; 88(6):3527-47. PubMed ID: 24403588
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.
Chu H; Das SC; Fuchs JF; Suresh M; Weaver SC; Stinchcomb DT; Partidos CD; Osorio JE
Vaccine; 2013 Jul; 31(33):3353-60. PubMed ID: 23727003
[TBL] [Abstract][Full Text] [Related]
15. Expression of anti-chikungunya single-domain antibodies in transgenic
Webb EM; Compton A; Rai P; Chuong C; Paulson SL; Tu Z; Weger-Lucarelli J
Front Microbiol; 2023; 14():1189176. PubMed ID: 37378291
[TBL] [Abstract][Full Text] [Related]
16. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease.
Mota MTO; Costa VV; Sugimoto MA; Guimarães GF; Queiroz-Junior CM; Moreira TP; de Sousa CD; Santos FM; Queiroz VF; Passos I; Hubner J; Souza DG; Weaver SC; Teixeira MM; Nogueira ML
Sci Rep; 2020 Mar; 10(1):5306. PubMed ID: 32210270
[TBL] [Abstract][Full Text] [Related]
17. 4'-Fluorouridine inhibits alphavirus replication and infection
Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
[TBL] [Abstract][Full Text] [Related]
18. Emerging alphaviruses in the Americas: Chikungunya and Mayaro.
Figueiredo ML; Figueiredo LT
Rev Soc Bras Med Trop; 2014; 47(6):677-83. PubMed ID: 25626645
[TBL] [Abstract][Full Text] [Related]
19. The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus.
de Castro-Jorge LA; de Carvalho RVH; Klein TM; Hiroki CH; Lopes AH; Guimarães RM; Fumagalli MJ; Floriano VG; Agostinho MR; Slhessarenko RD; Ramalho FS; Cunha TM; Cunha FQ; da Fonseca BAL; Zamboni DS
PLoS Pathog; 2019 Sep; 15(9):e1007934. PubMed ID: 31479495
[TBL] [Abstract][Full Text] [Related]
20. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.
Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG
mSphere; 2018; 3(2):. PubMed ID: 29577083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
